Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT06360861Phase 1Completed
Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Mesenchymal Stem CellsMultiple SclerosisSecondary-Progressive Multiple Sclerosis
StudydirectorStart date: 2019-07-23

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Multiple Sclerosis Research Center,Neuroscience Institute,Sina Hospital,Tehran, Iran.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mohsen Nikbakht, PhD

Research Institute for Oncology, Hematology& Cell Therapy Facility, Shariati Hospital ,Tehran, Iran.

Moderately Similar
1 trials

Shared therapeutic areas:

Mesenchymal Stem CellsMultiple SclerosisMultiple Sclerosis, Secondary Progressive

Worked with same sponsors:

Tehran University of Medical Sciences
Collaborated on 1 trial
Similarity Score34%

Ameneh Shokati, PhD

Applied Cell Sciences,Tehran University of Medical Sciences,Tehran, Iran.

Moderately Similar
1 trials

Shared therapeutic areas:

Mesenchymal Stem CellsMultiple SclerosisMultiple Sclerosis, Secondary Progressive

Worked with same sponsors:

Tehran University of Medical Sciences
Collaborated on 1 trial
Similarity Score34%

İsmail ÖZSOY, Assoc. Prof. Dr.

Selcuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Konya, Türkiye

Related
10 trials

Shared therapeutic areas:

Multiple Sclerosis
Similarity Score10%

Todd Janus, MD, PhD

Iowa Health Des Moines

Related
1 trials

Shared therapeutic areas:

Multiple Sclerosis
Similarity Score10%

Kiren Kresa-Reahl, MD

Charleston Area Medical Center Health Education and Research Institute, Inc.

Related
1 trials

Shared therapeutic areas:

Multiple Sclerosis
Similarity Score10%

Dina Jacobs, MD

University of Pennsylvania

Related
1 trials

Shared therapeutic areas:

Multiple Sclerosis
Similarity Score10%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Multiple Sclerosis

Worked with same sponsors:

Tehran University of Medical Sciences
Similarity Score10%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Multiple Sclerosis
Similarity Score10%

Geoffery Eubank, MD

Neurological Research Institute

Related
1 trials

Shared therapeutic areas:

Multiple Sclerosis
Similarity Score10%

Syed Rizvi, MD

Rhode Island Hospital

Related
1 trials

Shared therapeutic areas:

Multiple Sclerosis
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06360861Phase 1StudyDirector

Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis

Mesenchymal Stem CellsMultiple SclerosisSecondary-Progressive Multiple Sclerosis
Completed

All 1 trials loaded